About Onc.ai
Onc.ai is a company based in San Carlos (United States) founded in 2020 by Salmaan Ahmed. Onc.ai has raised $31 million across 3 funding rounds from investors including MassMutual, HHS and Action Potential Venture Capital. Onc.ai operates in a competitive market with competitors including Lunit, Median, Avenda Health, Aidence and SimBioSys, among others.
- Headquarter San Carlos, United States
- Founders Salmaan Ahmed
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$31 M (USD)
in 3 rounds
-
Latest Funding Round
$1.63 M (USD), Grant
Sep 13, 2024
-
Investors
MassMutual
& 12 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Onc.ai
Unlock access to complete
Unlock access to complete
Funding Insights of Onc.ai
Onc.ai has successfully raised a total of $31M across 3 strategic funding rounds. The most recent funding activity was a Grant round of $1.63 million completed in September 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Onc.ai
Onc.ai has secured backing from 13 investors, including institutional, venture fund, and angel investors. Prominent investors backing the company include MassMutual, HHS and Action Potential Venture Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Stage-agnostic investments in US life sciences are pursued.
|
Locked | Locked | Locked | |
|
Venture capital firm focused on tech sectors
|
Locked | Locked | Locked | |
|
Funding is provided to healthcare startups by corporate-backed BVF.
|
Locked | Locked | Locked |
Investor details for Onc.ai
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Onc.ai
Investment portfolio details for Onc.ai
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Onc.ai
Detailed financials for Onc.ai
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Onc.Ai Comparisons
Peer comparison for Onc.ai
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Onc.ai
Onc.ai operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Lunit, Median, Avenda Health, Aidence and SimBioSys, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Artificial intelligence solutions for cancer detection and treatment are developed.
|
|
| Locked | Locked | Locked |
Medical imaging software and services are provided for clinical trials.
|
|
| Locked | Locked | Locked |
Developer of a focal therapy system to treat prostate cancer
|
|
| Locked | Locked | Locked |
Medical images are analyzed using deep learning for radiologists.
|
|
| Locked | Locked | Locked |
AI-based cancer diagnosis tools are provided for healthcare professionals.
|
Detailed competitors of Onc.ai
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Onc.Ai
Complete news archive for Onc.ai
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Onc.ai
Onc.ai was founded in 2020.
Onc.ai is headquartered in San Carlos, United States. It is registered at San Carlos, California, United States.
Onc.ai is a funded company, having raised a total of $31M across 3 funding rounds to date.
Onc.ai was founded in 2020 and is headquartered in San Carlos, United States. The company operates in the healthcare sector, where an AI-based platform is developed to support cancer treatment and diagnosis. Decision-making processes for providers are assisted through integration of AI technology, genomics, proteomics, and radionics. Services focus on enhancing clinical workflows in oncology.
Onc.ai's top competitors include Lunit, Median and Avenda Health.
Onc.ai has 13 investors. Key investors include MassMutual, HHS, Action Potential Venture Capital, Life Extension Ventures, and BVF.